334 related articles for article (PubMed ID: 16952708)
1. The role of serotonin (5-hydroxytryptamine1A and 1B) receptors in prostate cancer cell proliferation.
Siddiqui EJ; Shabbir M; Mikhailidis DP; Thompson CS; Mumtaz FH
J Urol; 2006 Oct; 176(4 Pt 1):1648-53. PubMed ID: 16952708
[TBL] [Abstract][Full Text] [Related]
2. The effect of serotonin and serotonin antagonists on bladder cancer cell proliferation.
Siddiqui EJ; Shabbir MA; Mikhailidis DP; Mumtaz FH; Thompson CS
BJU Int; 2006 Mar; 97(3):634-9. PubMed ID: 16469039
[TBL] [Abstract][Full Text] [Related]
3. Growth inhibitory effect of doxazosin on prostate and bladder cancer cells. Is the serotonin receptor pathway involved?
Siddiqui EJ; Shabbir M; Thompson CS; Mumtaz FH; Mikhailidis DP
Anticancer Res; 2005; 25(6B):4281-6. PubMed ID: 16309229
[TBL] [Abstract][Full Text] [Related]
4. Expression of serotonin receptors and role of serotonin in human prostate cancer tissue and cell lines.
Dizeyi N; Bjartell A; Nilsson E; Hansson J; Gadaleanu V; Cross N; Abrahamsson PA
Prostate; 2004 May; 59(3):328-36. PubMed ID: 15042609
[TBL] [Abstract][Full Text] [Related]
5. Serotonin and melatonin do not play a prominent role in the growth of prostate cancer cell lines.
Pirozhok I; Meye A; Hakenberg OW; Fuessel S; Wirth MP
Urol Int; 2010; 84(4):452-60. PubMed ID: 20234124
[TBL] [Abstract][Full Text] [Related]
6. Expression of serotonin receptors 2B and 4 in human prostate cancer tissue and effects of their antagonists on prostate cancer cell lines.
Dizeyi N; Bjartell A; Hedlund P; Taskén KA; Gadaleanu V; Abrahamsson PA
Eur Urol; 2005 Jun; 47(6):895-900. PubMed ID: 15925089
[TBL] [Abstract][Full Text] [Related]
7. Expression of Nkx3.1 enhances 17beta-estradiol anti-tumor action in PC3 human prostate cancer cells.
Wang P; Liu B; Luo JD; Zhang ZG; Ma Q; Chen ZD
Asian J Androl; 2007 May; 9(3):353-60. PubMed ID: 17486276
[TBL] [Abstract][Full Text] [Related]
8. Effect of leuprolide and cetrorelix on cell growth, apoptosis, and GnRH receptor expression in primary cell cultures from human prostate carcinoma.
Castellón E; Clementi M; Hitschfeld C; Sánchez C; Benítez D; Sáenz L; Contreras H; Huidobro C
Cancer Invest; 2006; 24(3):261-8. PubMed ID: 16809153
[TBL] [Abstract][Full Text] [Related]
9. Reduced tumor growth in vivo and increased c-Abl activity in PC3 prostate cancer cells overexpressing the Shb adapter protein.
Davoodpour P; Landström M; Welsh M
BMC Cancer; 2007 Aug; 7():161. PubMed ID: 17697368
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of cysteinyl LT1 receptor in prostate cancer and CysLT1R antagonist inhibits prostate cancer cell growth through apoptosis.
Matsuyama M; Hayama T; Funao K; Kawahito Y; Sano H; Takemoto Y; Nakatani T; Yoshimura R
Oncol Rep; 2007 Jul; 18(1):99-104. PubMed ID: 17549353
[TBL] [Abstract][Full Text] [Related]
11. The inhibitory effects of gossypol on human prostate cancer cells-PC3 are associated with transforming growth factor beta1 (TGFbeta1) signal transduction pathway.
Jiang J; Sugimoto Y; Liu S; Chang HL; Park KY; Kulp SK; Lin YC
Anticancer Res; 2004; 24(1):91-100. PubMed ID: 15015581
[TBL] [Abstract][Full Text] [Related]
12. Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis in androgen-independent human prostate cancer cell lines.
Kim IY; Kim BC; Seong DH; Lee DK; Seo JM; Hong YJ; Kim HT; Morton RA; Kim SJ
Cancer Res; 2002 Sep; 62(18):5365-9. PubMed ID: 12235008
[TBL] [Abstract][Full Text] [Related]
13. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
Izumi K; Mizokami A; Li YQ; Narimoto K; Sugimoto K; Kadono Y; Kitagawa Y; Konaka H; Koh E; Keller ET; Namiki M
Prostate; 2009 Aug; 69(11):1222-34. PubMed ID: 19434660
[TBL] [Abstract][Full Text] [Related]
14. Exogenous serotonin regulates proliferation of interstitial cells of Cajal in mouse jejunum through 5-HT2B receptors.
Wouters MM; Gibbons SJ; Roeder JL; Distad M; Ou Y; Strege PR; Szurszewski JH; Farrugia G
Gastroenterology; 2007 Sep; 133(3):897-906. PubMed ID: 17854596
[TBL] [Abstract][Full Text] [Related]
15. Hormone-refractory prostate cancer cells express functional follicle-stimulating hormone receptor (FSHR).
Ben-Josef E; Yang SY; Ji TH; Bidart JM; Garde SV; Chopra DP; Porter AT; Tang DG
J Urol; 1999 Mar; 161(3):970-6. PubMed ID: 10022736
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of digitalis on the proliferation of androgen dependent and independent prostate cancer cells.
Yeh JY; Huang WJ; Kan SF; Wang PS
J Urol; 2001 Nov; 166(5):1937-42. PubMed ID: 11586264
[TBL] [Abstract][Full Text] [Related]
17. Differential involvement of reactive oxygen species and nucleoside transporters in cytotoxicity induced by two adenosine analogues in human prostate cancer cells.
Minelli A; Bellezza I; Tucci A; Rambotti MG; Conte C; Culig Z
Prostate; 2009 Apr; 69(5):538-47. PubMed ID: 19107848
[TBL] [Abstract][Full Text] [Related]
18. The role of serotonin in tumour growth (review).
Siddiqui EJ; Thompson CS; Mikhailidis DP; Mumtaz FH
Oncol Rep; 2005 Dec; 14(6):1593-7. PubMed ID: 16273262
[TBL] [Abstract][Full Text] [Related]
19. The cannabinoid R+ methanandamide induces IL-6 secretion by prostate cancer PC3 cells.
Olea-Herrero N; Vara D; Malagarie-Cazenave S; Díaz-Laviada I
J Immunotoxicol; 2009 Dec; 6(4):249-56. PubMed ID: 19908944
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of cholesterol and phytosterols on cell proliferation, apoptosis and expression of a prostate specific gene in prostate cancer cell lines.
Ifere GO; Barr E; Equan A; Gordon K; Singh UP; Chaudhary J; Igietseme JU; Ananaba GA
Cancer Detect Prev; 2009; 32(4):319-28. PubMed ID: 19186008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
